Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill

Amber Tong

Zachary Brennan

Senior Editor

Just a day after Pfizer and BioNTech announced the start of trials for their Omicron-specific vaccine booster candidate, Moderna put out word that it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill

Amber Tong

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Mod­er­na kicks off tri­al for Omi­cron-spe­cif­ic vac­cine; EMA signs off on Pfiz­er pill

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill